Vivani Medical, Inc.
Vivani Medical, Inc. (Nasdaq Capital Market) is a clinical-stage biopharmaceutical company developing miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology platform. The company's website is vivanimedical.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Vivani Medical, Inc. does
In the company’s own words
Vivani Medical, Inc. (Nasdaq Capital Market) is a clinical-stage biopharmaceutical company developing miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology platform. The company's website is vivanimedical.com.
Vivani's core business focuses on designing and developing drug implant candidates engineered to enable reversible, ultra long-acting, near constant-rate delivery of therapeutic medicines for treating chronic diseases. The company addresses a significant healthcare challenge: approximately fifty percent of patients do not take their prescribed medications as directed, whether daily oral or weekly injectable formulations. This medication non-adherence contributes to poor clinical outcomes and substantial healthcare costs.
The company's lead programs target metabolic diseases. NPM-139 is a semaglutide implant candidate in development for chronic weight management in obese and overweight patients, anticipated to enter clinical testing in mid-2026. NPM-133, also a semaglutide implant, targets type 2 diabetes treatment. NPM-115 is an exenatide implant for chronic weight management that completed its first-in-human clinical trial, LIBERATE-1, in 2025, demonstrating positive safety and tolerability profiles. OKV-119, developed in collaboration with partner Okava Pharmaceuticals, is an exenatide implant under development for obesity and diabetes treatment in companion cats and dogs.
Vivani's NanoPortal technology utilizes a biocompatible titanium-oxide nano-porous membrane with precisely sized nanotubes enabling near constant drug release without moving parts. The implants are designed to deliver therapeutic drug levels for six months or longer with convenient once or twice yearly administration while maintaining the ability to be removed at any time.
The company resulted from the August 2022 merger of Second Sight Medical Products and Nano Precision Medical. Vivani subsequently contributed Second Sight's neurostimulation assets to Cortigent, a wholly owned subsidiary, which is pursuing a separate public listing through either an initial public offering or spin-off transaction.
Vivani operates manufacturing facilities in Alameda and San Diego, California, and maintains a subsidiary in Australia supporting clinical development activities. The company competes within the GLP-1 receptor agonist market, which generated approximately seventy-two billion dollars in combined global sales across obesity and type 2 diabetes indications in 2025.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- ALAMEDA, CA
- Fiscal year end
- December
- CIK
- 1266806
- SIC
- 3845
Financial performance, year by year
Fiscal 2015–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Vivani Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Vivani Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Vivani Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Vivani Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Vivani Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”